DGAP-Adhoc

STADA Arzneimittel AG: Sales and earnings targets for 2014 at Group level met - crisis in the market region CIS/Eastern Europe requires impairments on goodwill as well as on further intangible assets in the expected amount of Euro 76.0 million before taxe - Seite 2

1,327.5 million (December 31, 2013: Euro 1,306.8 million). The net debt to
adjusted EBITDA ratio is anticipated to have decreased to 3.1 in financial
year 2014 (previous year: 3.2).

Cash flow from operating activities is expected to have amounted to Euro
223.8 million in financial year 2014 (previous year: Euro 203.7 million).
Free cash flow is anticipated to have amounted to Euro -38.2 million
(previous year: Euro -108.2 million). Free cash flow adjusted for payments
for significant investments or acquisitions and proceeds from significant
disposals is expected to have amounted to Euro 157.4 million (previous
year: Euro 133.3 million).

For the preliminary outlook for 2015, the Executive Board currently
anticipates growth in Group sales adjusted for currency and portfolio
effects. From today's perspective, the Executive Board however expects a
decreased earnings contribution from Russia due to the recent developments
of the Russian ruble and increased risks in connection with consumer mood
and the general market situation. Taking these developments into account
and based on current currency relations, the Executive Board expects from
today's perspective a substantial decrease in adjusted EBITDA and adjusted
net income.

STADA will publish its final figures for financial year 2014 including a
definitive forecast for financial year 2015 on March 26, 2015.

STADA key figures

                             2014                 2013                 +/-

Group sales                  Euro 2.062.2 million Euro 2,003.9 million +3%

EBITDA, reported             Euro 418.8 million   Euro 382.6 million   +9%

EBITDA, adjusted             Euro 431.9 million   Euro 414.3 million   +4%

Net income, reported         Euro 64.6 million    Euro 121.4 million   -47%

Net income, adjusted         Euro 186.2 million   Euro 160.6 million   +16%

Earnings per share           Euro 1.07            Euro 2.04            -48%

Earnings per share, adjusted Euro 3.08            Euro 2.70            +14%

STADA adjustments

                                                                   2014

Net income, reported                                               Euro
                                                                   64.6
                                                                   million

One-time effects

Burden from impairments on goodwill including the market region    + Euro